抗癫痫药物与骨代谢的相关性研究的进展
Research Progress on the Relationship between Antiepileptic Drugs and Bone Metabolism
摘要: 癫痫是一种常见的慢性神经系统疾病，目前癫痫治疗仍以药物治疗为主。大多数抗癫痫药物(antiepileptic drugs, AEDs)都有不同程度的不良反应，其中一个主要的问题是AEDs对骨骼健康的影响。约50%服用AEDs的癫痫患者会出现骨骼异常，主要表现在骨代谢及骨密度方面。但早期AEDs对骨代谢的影响较容易被患者及临床医生忽视。本文主要从AEDs对骨代谢影响的早期监测、影响机制及预防治疗等方面进行阐述，为临床上AEDs药物的选择及AEDs相关骨异常患者的预防治疗提供一定的理论依据。
Abstract: Epilepsy is a common chronic nervous system disease. Epilepsy treatment is still based on drug therapy. Most antiepileptic drugs (AEDs) have different degrees of adverse reactions, and one of the main problems is the effect of AEDs on bone health. About 50% of epilepsy patients taking AEDs will have bone abnormalities, mainly in bone metabolism and bone density. However, the effect of early AEDs on bone metabolism is easy to be ignored by patients and clinicians. In this paper, the effects of AEDs on bone metabolism were mainly discussed from the aspects of early monitoring, influence mechanism and prevention and treatment, so as to provide certain theoretical basis for the selection of clinical AEDs drugs and the prevention and treatment of AEDs related bone abnormalities.
文章引用：安文娜, 高学军. 抗癫痫药物与骨代谢的相关性研究的进展[J]. 临床医学进展, 2020, 10(8): 1827-1832. https://doi.org/10.12677/ACM.2020.108275

参考文献

[1] Moshé, S.L., Perucca, E., Ryvlin, P. and Tomson, T. (2015) Epilepsy: New Advances. The Lancet, 385, 884-898. [Google Scholar] [CrossRef] 
[2] Naylor, J., Thevathasan, A., Churilov, L., et al. (2018) Association between Different Acute Stroke Therapies and Development of Post Stroke Seizures. BMC Neurology, 18, Article No. 61. [Google Scholar] [CrossRef] [PubMed]
[3] Hamed, S.A., Radwan, M.E.N., Haridi, M.A., et al. (2014) Thyroid Gland Volume in Adults with Epilepsy: Relationship to Thyroid Hormonal Function. Neurology and Neuroscience, 5, 2.
[4] Hamed, S.A., et al. (2015) Evaluation of Penile Vascular Status in Men with Epilepsy with Erectile Dysfunction. Seizure, 25, 40-48. [Google Scholar] [CrossRef] [PubMed]
[5] Lazzari, A.A., Dussault, P.M., Thakore-James, M., et al. (2013) Prevention of Bone Loss and Vertebral Fractures in Patients with Chronic Epilepsy—Antiepileptic Drug and Osteoporosis Prevention Trial. Epilepsia, 54, 1997-2004. [Google Scholar] [CrossRef] [PubMed]
[6] Abeş, M., Sarihan, H. and Madenci, E. (2003) Evaluation of Bone Mineral Density with Dual X-Ray Absorptiometry for Osteoporosis in Children with Bladder Augmentation. Journal of Pediatric Surgery, 38, 230-232. [Google Scholar] [CrossRef] [PubMed]
[7] Eastell, R. and Hannon, R.A. (2008) Biomarkers of Bone Health and Osteoporosis Risk: Symposium on “Diet and Bone Health”. Proceedings of the Nutrition Society, 67, 157-162. [Google Scholar] [CrossRef] 
[8] Shen, C., Chen, F., Zhang, Y., Guo, Y. and Ding, M. (2014) Association between Use of Antiepileptic Drugs and Fracture Risk: A Systematic Review and Meta-Analysis. Bone, 64, 246-253. [Google Scholar] [CrossRef] [PubMed]
[9] Fan, D., Miao, J., Fan, X., Wang, Q. and Sun, M. (2019) Effects of Valproic Acid on Bone Mineral Density and Bone Metabolism: A Meta-Analysis. Seizure, 73, 56-63. [Google Scholar] [CrossRef] [PubMed]
[10] Koo, D.L., Hwang, K.J., Han, S.W., et al. (2014) Effect of Oxcarbazepine on Bone Mineral Density and Biochemical Markers of Bone Metabolism in Patients with Epilepsy. Epilepsy Research, 108, 442-447. [Google Scholar] [CrossRef] [PubMed]
[11] Cansu, A., Yesilkaya, E., Serdaroğlu, A., et al. (2008) Evaluation of Bone Turnover in Epileptic Children Using Oxcarbazepine. Pediatric Neurology, 39, 266-271. [Google Scholar] [CrossRef] [PubMed]
[12] Nissen-Meyer, L.S., Svalheim, S., Taubøll, E., et al. (2007) Levetiracetam, Phenytoin, and Valproate Act Differently on Rat Bone Mass, Structure, and Metabolism. Epilepsia, 48, 1850-1860. [Google Scholar] [CrossRef] [PubMed]
[13] Koo, D.L., Joo, E.Y., Kim, D. and Hong, S.B. (2013) Effects of Levetiracetam as a Monotherapy on Bone Mineral Density and Biochemical Markers of Bone Metabolism in Patients with Epilepsy. Epilepsy Research, 104, 134-139. [Google Scholar] [CrossRef] [PubMed]
[14] Fekete, S., Simko, J., Gradosova, I., et al. (2013) Erratum to “The Effect of Levetiracetam on Rat Bone Mass, Structure and Metabolism” [Epilepsy Res. 107 (2013) 56-60]. Epilepsy Research, 107, 56-60. [Google Scholar] [CrossRef] 
[15] 张静, 王凯旋, 韦翊, 等. 托吡酯和卡马西平对癫痫患儿骨代谢的影响[J]. 中国当代儿科杂志, 2010, 12(2): 96-98.
[16] Heo, K., Rhee, Y., Lee, H.W., et al. (2011) The Effect of Topiramate Monotherapy on Bone Mineral Density and Markers of Bone and Mineral Metabolism in Premenopausal Women with Epilepsy. Epilepsia, 52, 1884-1889. [Google Scholar] [CrossRef] [PubMed]
[17] Arora, E., Singh, H. and Gupta, Y.K. (2016) Impact of Antiepileptic Drugs on Bone Health: Need for Monitoring, Treatment, and Prevention Strategies. Journal of Family Medicine and Primary Care, 5, 248-253. [Google Scholar] [CrossRef] [PubMed]
[18] Mikati, M.A., Dib, L., Yamout, B., Sawaya, R., Rahi, A.C. and Fuleihan, G.-H. (2006) Two Randomized Vitamin D Trials in Ambulatory Patients on Anticonvulsants: Impact on Bone. Neurology, 67, 2005-2014. [Google Scholar] [CrossRef] [PubMed]
[19] Lee, H.S., Wang, S.Y., Salter, D.M., Wang, C.C., Chen, S.J. and Fan, H.C. (2013) The Impact of the Use of Antiepileptic Drugs on the Growth of Children. BMC Pediatrics, 13, Article No. 211. [Google Scholar] [CrossRef] [PubMed]
[20] Svalheim, S., Sveberg, L., Mochol, M. and Taubøll, E. (2015) Interactions between Antiepileptic Drugs and Hormones. Seizure, 28, 12-17. [Google Scholar] [CrossRef] [PubMed]
[21] Kim, D.W., Lee, S.Y., Shon, Y.M. and Kim, J.H. (2013) Effects of New Antiepileptic Drugs on Circulatory Markers for Vascular Risk in Patients with Newly Diagnosed Epilepsy. Epilepsia, 54, e146-e149. [Google Scholar] [CrossRef] [PubMed]
[22] Behera, J., Bala, J., Nuru, M., Tyagi, S.C. and Tyagi, N. (2017) Homocysteine as a Pathological Biomarker for Bone Disease. Journal of Cellular Physiology, 232, 2704-2709. [Google Scholar] [CrossRef] [PubMed]
[23] Yazdanpanah, N., Zillikens, M.C., Rivadeneira, F., et al. (2007) Effect of Dietary B Vitamins on BMD and Risk of Fracture in Elderly Men and Women: The Rotterdam Study. Bone, 41, 987-994. [Google Scholar] [CrossRef] [PubMed]
[24] Karsenty, G. (2006) Convergence between Bone and Energy Homeostases: Leptin Regulation of Bone Mass. Cell Metabolism, 4, 341-348. [Google Scholar] [CrossRef] [PubMed]
[25] Takeda, S. and Karsenty, G. (2008) Molecular Bases of the Sympathetic Regulation of Bone Mass. Bone, 42, 837-840. [Google Scholar] [CrossRef] [PubMed]
[26] Berghuis, B., Van Der Palen, J., DE Haan, G.J., et al. (2017) Carbamazepine- and Oxcarbazepine-Induced Hyponatremia in People with Epilepsy. Epilepsia, 58, 1227-1233. [Google Scholar] [CrossRef] [PubMed]
[27] Kinsella, S., Moran, S., Sullivan, M.O., Molloy, M.G. and Eustace, J.A. (2010) Hyponatremia independent of Osteoporosis Is Associated with Fracture Occurrence. Clinical Journal of the American Society of Nephrology, 5, 275-280. [Google Scholar] [CrossRef] 
[28] Diemar, S.S., Sejling, A.S., Eiken, P., Suetta, C., Jørgensen, N.R. and Andersen, N.B. (2019) Hyponatremia and Metabolic Bone Disease in Patients with Epilepsy: A Cross-Sectional Study. Bone, 123, 67-75. [Google Scholar] [CrossRef] [PubMed]
[29] Erbayat Altay, E., Serdaroğlu, A., Tümer, L., Gücüyener, K. And Hasanoğlu, A. (2000) Evaluation of Bone Mineral Metabolism in Children Receiving Carbamazepine and Valproic Acid. Journal of Pediatric Endocrinology and Metabolism, 13, 933-939. [Google Scholar] [CrossRef] 

为你推荐